Acticor initiates phase II trial of glenzocimab to treat COVID-19 related ARDS Dec. 23, 2020 No Comments
Vasomune initiates first-in-human study of AV-001 as potential therapy for COVID-19 and ARDS Dec. 18, 2020 No Comments
New phase III trial evaluates siltuximab for COVID-19 or viral-associated ARDS Dec. 17, 2020 No Comments
European Commission approves Trixeo Aerosphere for maintenance treatment of COPD Dec. 15, 2020 No Comments
Lyra Therapeutics presents positive data from phase II LANTERN study of LYR-210 Dec. 9, 2020 No Comments
RSS